InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+23.9%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Clemmer James C, Chairman & CEO. Insider active across 1 company, notably Angiodynamics INC. Cumulatively, 36 reports have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €624k. History available since 14 July 2021. The latest transaction was filed on 22 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Clemmer James C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations36 total
52,358 shares0Common StockSEC:0001140361-26-029633:0
26,728 shares@ US$13.820.066% mcap16.6% of flowCommon StockSEC:0001140361-26-029633:1
18,588 shares@ US$14.140.047% mcap14.1% of flowCommon StockSEC:0001140361-26-029178:0
11,764 shares@ US$13.510.028% mcap8.6% of flowCommon StockSEC:0001140361-26-029178:2
10,649 shares@ US$13.510.026% mcap7.7% of flowCommon StockSEC:0001140361-26-029178:1
487 shares@ US$13.510.0012% mcap0.4% of flowCommon StockSEC:0001140361-26-029178:3
4,223 shares@ US$13.710.010% mcap3.1% of flowCommon StockSEC:0001140361-26-029178:4
10,000 shares@ US$11.159.0% of flowCommon StockSEC:0001140361-25-037836:0
Canonical exit: 7 Jan 2026 (T+90)
344 shares@ US$8.690.2% of flowCommon StockSEC:0001140361-25-026797:0
8,307 shares@ US$8.694.7% of flowCommon StockSEC:0001140361-25-026797:1
2,982 shares@ US$8.691.7% of flowCommon StockSEC:0001140361-25-026797:2
3,673 shares@ US$8.992.1% of flowCommon StockSEC:0001140361-25-026797:3
206,253 shares0Common StockSEC:0001140361-25-026464:0
20,000 shares@ US$6.038.3% of flowCommon StockSEC:0001140361-24-043157:0
Canonical exit: 5 Jan 2025 (T+90)
56,279 shares0Common StockSEC:0001140361-24-035600:0
2,982 shares@ US$7.131.5% of flowCommon StockSEC:0001140361-24-034270:0
8,307 shares@ US$7.184.1% of flowCommon StockSEC:0001140361-24-033784:0
3,817 shares0Common StockSEC:0001140361-24-033912:0
105,811 shares0Common StockSEC:0001140361-24-033635:0
10,000 shares@ US$6.704.6% of flowCommon StockSEC:0001140361-24-018620:0
Canonical exit: 7 Jul 2024 (T+90)
69,676 shares0Common StockSEC:0001140361-23-044830:0
31,572 shares0Common StockSEC:0001140361-23-036322:0
2,982 shares@ US$8.741.8% of flowCommon StockSEC:0001140361-23-036120:0
3,372 shares@ US$8.652.0% of flowCommon StockSEC:0001140361-23-036120:1
92,181 shares0Common StockSEC:0001140361-23-035729:0
25 of 36 declarations
About Clemmer James C
Clemmer James C is Président-Directeur Général and is linked to Angiodynamics INC, where he holds the role of President and CEO. The declarant has 29 filings in total, and across the recent filings available, buys amount to EUR 624012 and sells to EUR 0, between 2021-07-23 and 2025-10-09; the most frequent transaction nature is Tax withholding.
